This website is now the new JPND's archival platform. This website hosts all of JPND's archived content and resources.
Please continue to visit this site to access publications, videos and reports from JPND's activities.

Dev

Joined: October 9, 2025
Articles: 6278

Research News (General)

Regulating neuronal membrane lipids could be the key to Alzheimer’s and Parkinson’s

A study published in Scientific Reports demonstrates, for the first time and using computational tools, that polyunsaturated lipids can alter the binding rate of two types of receivers involved in certain nervous system diseases. Using latest-generation molecular simulations, which are…

Dev
March 11, 2016

Research News (General)

Immune cells ‘prune’ connections between neurons

A new study in the journal Nature Communications shows that cells normally associated with protecting the brain from infection and injury also play an important role in rewiring the connections between nerve cells. While this discovery sheds new light on…

Dev
March 11, 2016

views

Judes Poirier, McGill University – BIOMARKAPD researcher

Professor Judes Poirier of McGill University and the Douglas Institute in Montreal, Canada, was a participant in BIOMARKAPD, a JPND project on biomarkers for Alzheimer’s disease and Parkinson’s disease that ran from 2012-2015. In an interview with JPND, he expounds…

Dev
March 3, 2016

JPND News

Living well with dementia: AAL 2016 call now open

The Active and Assisted Living Programme (AAL), which aims to improve the conditions of life for older adults through the use information and communication technology (ICT), has opened its 2016 call, Living well with dementia. The objective of the call…

Dev
March 1, 2016

views

Dinko Mitrecic, University of Zagreb, Croatia – member of the Management Board

“JPND is a unique European and global platform that has seen remarkable development over the last five years. First, it fills the gaps between policymakers, researchers, practitioners and patients. But even more importantly, it is assuming a primacy in the…

Dev
February 25, 2016

JPND News

2016 Alzheimer Europe Conference opens call for abstracts

Alzheimer Europe and Alzheimerforeningen are now accepting abstracts for the 26th Alzheimer Europe Conference, which will take place from October 31 – November 2, 2016, in Copenhagen, Denmark. Abstracts for oral and poster presentations can be submitted in the following…

Dev
February 15, 2016

views

Myrra Vernooij-Dassen, Nijmegen Centre for Evidence Based Practice, the Netherlands – member of the Scientific Advisory Board

“Behavioural problems are the key issues for people with dementia and for carers, and we have to focus on how we can improve the situation for them. I am also interested in the plasticity of the brain and how we…

Dev
February 8, 2016

JPND News

EMA opens consultation on revised guidelines on medicines to treat Alzheimer’s disease

The European Medicines Agency (EMA) has released draft revised guidelines on medicines for the treatment of Alzheimer’s disease and other types of dementias for a six-month public consultation. EMA follows a multi-stakeholder approach to facilitate research and development of more…

Dev
February 5, 2016

Research News (General)

A better model for Parkinson’s

Scientists have solved a longstanding problem with modeling Parkinson’s disease in animals. Using newfound insights, they improve both cell and animal models for the disease, which can propel research and drug development. Parkinson’s disease is characterized by the appearance of…

Dev
February 5, 2016

Research News (General)

Alzheimer’s disease: a new immunotherapy approach?

A study conducted on mice offers a new type of immunotherapy approach for treating Alzheimer’s disease. This involves amplifying a specific population of T lymphocytes that regulate immune and neuroinflammatory mechanisms that develop during the disease. These results are published…

Dev
February 5, 2016

Post

Post